NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

SCPH

scPharmaceuticals Inc

Apr 17 • 04:00PM ET

2.57

Dollar change +0.02
Percentage change 0.78	%

Healthcare • Biotechnology • USA • NASD

Peers: AMGN REGN GILD BIIB VRTX NBIX IONS EXEL INCY PBYI

| Held by: VTI IWM VXF IWO VTWO IWC VTWG RSSL QQQS IWV

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-1.91	Insider Own	31.88%	Shs Outstand	50.10M	Perf Week	27.54%
Market Cap	129.23M	Forward P/E	-	EPS next Y	-0.21	Insider Trans	0.00%	Shs Float	34.26M	Perf Month	-15.46%
Income	-85.15M	PEG	-	EPS next Q	-0.30	Inst Own	64.97%	Short Float	14.08%	Perf Quarter	-24.85%
Sales	36.33M	P/S	3.56	EPS this Y	48.68%	Inst Trans	11.23%	Short Ratio	10.50	Perf Half Y	-39.67%
Book/sh	0.27	P/B	9.67	EPS next Y	78.87%	ROA	-84.31%	Short Interest	4.82M	Perf Year	-44.97%
Cash/sh	1.50	P/C	1.71	EPS next 5Y	-	ROE	-336.97%	52W Range	1.94 - 5.65	Perf YTD	-27.40%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-1.52%	ROI	-129.46%	52W High	-54.51%	Beta	0.16
Dividend TTM	-	Quick Ratio	6.18	Sales past 5Y	33.46%	Gross Margin	68.43%	52W Low	32.47%	ATR (14)	0.24
Dividend Ex-Date	-	Current Ratio	7.12	EPS Y/Y TTM	-34.13%	Oper. Margin	-178.29%	RSI (14)	47.35	Volatility	10.39% 10.67%
Employees	164	Debt/Eq	3.96	Sales Y/Y TTM	167.28%	Profit Margin	-234.36%	Recom	1.00	Target Price	15.17
Option/Short	Yes / Yes	LT Debt/Eq	3.94	EPS Q/Q	1.01%	Payout	-	Rel Volume	0.54	Prev Close	2.55
Sales Surprise	0.55%	EPS Surprise	7.51%	Sales Q/Q	99.31%	Earnings	Mar 19 AMC	Avg Volume	459.32K	Price	2.57
SMA20	0.03%	SMA50	-13.43%	SMA200	-33.81%	Trades		Volume	249,629	Change	0.78%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-07-23	Initiated	Craig Hallum	Buy	$20
Dec-01-22	Initiated	Cowen	Outperform	$25
Oct-21-22	Resumed	Jefferies	Buy	$14
Oct-11-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$11
Aug-02-22	Initiated	Maxim Group	Buy	$10
Sep-09-21	Initiated	SVB Leerink	Mkt Perform	$6
Oct-15-19	Initiated	H.C. Wainwright	Buy	$13
Jan-30-19	Downgrade	Leerink Partners	Outperform → Mkt Perform

Mar-21-25 06:32PM	scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Report Preview: What To Expect (GuruFocus.com)
Mar-20-25 10:18AM	Q4 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
03:03AM	scPharmaceuticals Inc (SCPH) Q4 2024 Earnings Call Highlights: Revenue Surge and Strategic ... (GuruFocus.com)
Mar-19-25 07:14PM	ScPharmaceuticals outlines FUROSCIX expansion strategy with CKD launch in April 2025 (SeekingAlpha)
07:13PM	scPharmaceuticals Inc. (SCPH) Q4 2024 Earnings Call Transcript (SeekingAlpha)
05:10PM	Loading…
05:10PM	ScPharmaceuticals, Inc. (SCPH) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Update (GlobeNewswire)
Mar-12-25 04:01PM	scPharmaceuticals to Announce Fourth Quarter and Full Year 2024 Financial Results on Wednesday, March 19, 2025 (GlobeNewswire)
Mar-07-25 10:59AM	FDA approves scPharmaceuticals Furoscix sNDA for oedema in CKD (Pharmaceutical Technology) -6.09%
Mar-06-25 04:01PM	scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication to Include the Treatment of Edema in Patients with Chronic Kidney Disease (GlobeNewswire)
Mar-05-25 10:00AM	ScPharmaceuticals, Inc. (SCPH) Expected to Beat Earnings Estimates: Should You Buy? (Zacks)
Feb-26-25 04:01PM	scPharmaceuticals Announces Participation in Two Upcoming Investor Conferences (GlobeNewswire)
Feb-05-25 04:01PM	scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference (GlobeNewswire)
Jan-10-25 08:00AM	scPharmaceuticals Provides Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Nov-14-24 02:15AM	scPharmaceuticals Inc (SCPH) Q3 2024 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com) -14.07%
05:20PM	Loading…
Nov-13-24 05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Third Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Nov-06-24 04:01PM	scPharmaceuticals to Announce Third Quarter 2024 Financial Results on Wednesday, November 13, 2024 (GlobeNewswire) +6.63%
Oct-15-24 08:30AM	scPharmaceuticals to Host Key Opinion Leader (KOL) Webinar on October 22, 2024 (GlobeNewswire)
Sep-04-24 04:05PM	scPharmaceuticals to Present at the H.C. Wainwright 26th Annual Global Investment Conference (GlobeNewswire)
Aug-16-24 09:55AM	Does scPharmaceuticals (SCPH) Have the Potential to Rally 291.9% as Wall Street Analysts Expect? (Zacks)
Aug-15-24 11:57AM	Q2 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents) +5.64%
Aug-14-24 05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Second Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
Aug-12-24 09:48AM	scPharmaceuticals Announces Pricing of $50.0 Million Public Offering (GlobeNewswire)
06:05AM	scPharmaceuticals Announces Non-Dilutive Financings Totaling Up to $125 Million with Perceptive Advisors (GlobeNewswire)
06:04AM	scPharmaceuticals Announces FDA Approval of Supplemental New Drug Application Expanding the FUROSCIX Indication in Heart Failure (GlobeNewswire)
06:02AM	scPharmaceuticals Announces Positive Topline Study Results for SCP-111 (Furosemide 80 mg/1 mL) Autoinjector (GlobeNewswire)
06:00AM	scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock and Pre-Funded Warrants (GlobeNewswire)
Aug-08-24 04:05PM	scPharmaceuticals to Announce Second Quarter 2024 Financial Results on Wednesday, August 14, 2024 (GlobeNewswire) +7.38%
08:00AM	Loading…
Jul-25-24 08:00AM	scPharmaceuticals Announces Filing Acceptance of Supplemental New Drug Application (sNDA) Seeking to Expand FUROSCIX Indication to Include Chronic Kidney Disease (GlobeNewswire)
Jul-15-24 11:57AM	7 Short-Squeeze Stocks That Could Beat Down the Bears (InvestorPlace)
Jun-05-24 12:55PM	These 2 Strong Buy Penny Stocks Are Poised for a Massive Rally, Say Analysts (TipRanks) +10.45%
May-29-24 04:01PM	scPharmaceuticals to Present at the Jefferies Global Healthcare Conference (GlobeNewswire)
May-15-24 11:44AM	Q1 2024 scPharmaceuticals Inc Earnings Call (Thomson Reuters StreetEvents)
08:18AM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2024 Earnings Call Transcript (Insider Monkey)
03:09AM	scPharmaceuticals Inc (SCPH) (Q1 2024) Earnings Call Transcript Highlights: Navigating ... (GuruFocus.com)
May-14-24 08:56PM	SCPH Stock Earnings: scPharmaceuticals Beats EPS, Beats Revenue for Q1 2024 (InvestorPlace)
05:20PM	ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Lags Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports First Quarter 2024 Financial Results and Provides Business Update (GlobeNewswire)
May-13-24 04:05PM	scPharmaceuticals to Present at the H.C. Wainwright 2nd Annual BioConnect Investor Conference (GlobeNewswire)
May-07-24 04:05PM	scPharmaceuticals to Announce First Quarter 2024 Financial Results on Tuesday, May 14, 2024 (GlobeNewswire)
Apr-24-24 08:00AM	scPharmaceuticals Announces First Participant Enrolled in Pivotal Pharmacokinetic Study of FUROSCIX Auto-Injector (furosemide 80mg/mL) Injection (GlobeNewswire)
Mar-16-24 03:57PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-13-24 05:33PM	scPharmaceuticals Inc (SCPH) Reports Q4 and Full-Year 2023 Financials, Focusing on FUROSCIX Growth (GuruFocus.com)
04:01PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update (GlobeNewswire)
Mar-06-24 04:01PM	scPharmaceuticals to Announce Fourth Quarter and Full-Year 2023 Financial Results on Wednesday, March 13, 2024 (GlobeNewswire)
Feb-28-24 04:01PM	scPharmaceuticals to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Jan-04-24 04:05PM	scPharmaceuticals Announces Preliminary Unaudited Q4 and Full-Year 2023 Net FUROSCIX Revenue (GlobeNewswire)
Nov-09-23 01:02PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2023 Earnings Call Transcript (Insider Monkey) -8.74%
Nov-08-23 04:01PM	scPharmaceuticals Inc. Reports Third Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Nov-01-23 04:05PM	scPharmaceuticals to Announce Third Quarter 2023 Financial Results on Wednesday, November 8, 2023 (GlobeNewswire)
Oct-31-23 08:00AM	scPharmaceuticals to Participate in Two Upcoming Investor Conferences (GlobeNewswire)
Oct-05-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-19-23 08:00AM	scPharmaceuticals Announces Positive Feedback from Two FDA Meetings on Key Long-Term Growth Initiatives (GlobeNewswire)
Sep-05-23 08:00AM	scPharmaceuticals to Present at the H.C. Wainwright 25th Annual Global Investment Conference (GlobeNewswire)
Aug-10-23 05:40PM	ScPharmaceuticals, Inc. (SCPH) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports Second Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
Aug-03-23 08:00AM	scPharmaceuticals to Announce Second Quarter 2023 Financial Results on Thursday, August 10, 2023 (GlobeNewswire)
Aug-01-23 08:00AM	scPharmaceuticals Announces Positive Type C Meeting Feedback from FDA on Potential Heart Failure Class IV Indication Expansion (GlobeNewswire)
Jul-19-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jun-23-23 08:00AM	scPharmaceuticals Inc. Announces Addition to Russell 2000® and Russell 3000® Indexes (GlobeNewswire)
May-31-23 08:00AM	scPharmaceuticals to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-13-23 12:39PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-12-23 06:03AM	scPharmaceuticals (NASDAQ:SCPH) shareholders have earned a 155% return over the last year (Simply Wall St.)
May-10-23 05:15PM	ScPharmaceuticals, Inc. (SCPH) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	scPharmaceuticals Inc. Reports First Quarter 2023 Financial Results and Provides Business Update (GlobeNewswire)
May-02-23 08:00AM	scPharmaceuticals to Announce First Quarter 2023 Financial Results on Wednesday, May 10, 2023 (GlobeNewswire) +8.74%
Mar-27-23 07:12AM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-24-23 06:16AM	When Will scPharmaceuticals Inc. (NASDAQ:SCPH) Turn A Profit? (Simply Wall St.)
Mar-22-23 04:05PM	scPharmaceuticals Inc. Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update (GlobeNewswire) +25.14%
Mar-15-23 08:00AM	scPharmaceuticals to Announce Fourth Quarter and Full-Year 2022 Financial Results on Wednesday, March 22 (GlobeNewswire)
Feb-23-23 08:00AM	scPharmaceuticals to Participate in the Cowen 43rd Annual Health Care Conference (GlobeNewswire) +5.31%
Feb-21-23 08:00AM	scPharmaceuticals Announces Launch and Commercial Availability of FUROSCIX® (furosemide injection) (GlobeNewswire) -9.71%
Feb-06-23 08:00AM	scPharmaceuticals Inc. Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) (GlobeNewswire)
Jan-31-23 08:00AM	scPharmaceuticals to Participate in the SVB Securities Global Biopharma Conference (GlobeNewswire) +10.55%
Jan-30-23 08:00AM	scPharmaceuticals Provides FUROSCIX® (furosemide injection) Commercial Update (GlobeNewswire)
Jan-10-23 05:37AM	scPharmaceuticals Inc. (NASDAQ:SCPH) stock most popular amongst private equity firms who own 41%, while individual investors hold 36% (Simply Wall St.)
Dec-29-22 06:47PM	scPharmaceuticals Inc. (NASDAQ:SCPH) Q3 2022 Earnings Call Transcript (Insider Monkey) +5.78%
Dec-20-22 12:00PM	What Makes scPharmaceuticals, Inc. (SCPH) a New Buy Stock (Zacks)
09:40AM	Has scPharmaceuticals (SCPH) Outpaced Other Medical Stocks This Year? (Zacks)
Dec-19-22 08:00AM	scPharmaceuticals Inc. Announces Appointment of Rachael Nokes as Chief Financial Officer (GlobeNewswire)
Dec-14-22 08:00AM	scPharmaceuticals to Participate in the 12th Annual LifeSci Partners Corporate Access Event (GlobeNewswire)
Nov-22-22 08:01AM	scPharmaceuticals Announces Pricing of $50 Million Public Offering (GlobeNewswire) +14.45%
Nov-21-22 04:01PM	scPharmaceuticals Announces Proposed Underwritten Public Offering of Common Stock (GlobeNewswire)
Nov-09-22 04:30PM	Edited Transcript of SCPH.OQ earnings conference call or presentation 9-Nov-22 9:30pm GMT (Thomson Reuters StreetEvents) +12.27%
04:05PM	scPharmaceuticals Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Nov-02-22 08:00AM	scPharmaceuticals to Participate in the Jefferies London Healthcare Conference (GlobeNewswire)
Oct-26-22 08:00AM	scPharmaceuticals to Announce Third Quarter 2022 Financial Results and Host Conference Call on November 9, 2022 (GlobeNewswire) +5.84%
Oct-11-22 05:32PM	scPharmaceuticals (SCPH) Plunges Despite Furoscix's FDA Approval (Zacks) +39.30%
Oct-10-22 09:41AM	UPDATE - scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure (GlobeNewswire) -19.28%
09:24AM	FDA Approves scPharmaceuticals' Self-Administered Med For Congestion in Chronic Heart Failure (Benzinga)
08:05AM	scPharmaceuticals Announces $100 Million Debt Financing Agreement with Oaktree (GlobeNewswire)
08:00AM	scPharmaceuticals Announces FDA Approval of FUROSCIX® (furosemide injection), the First and Only Self-administered, Subcutaneous Loop Diuretic for the At-home Treatment of Congestion in Chronic Heart Failure (GlobeNewswire)
Sep-30-22 08:00AM	scPharmaceuticals Announces Data Presentations at the Heart Failure Society of America 2022 Annual Scientific Meeting (GlobeNewswire) +7.77%
Sep-01-22 08:00AM	scPharmaceuticals to Participate in the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-09-22 07:00AM	scPharmaceuticals Inc. Reports Second Quarter 2022 Financial Results and Provides Business Update (GlobeNewswire)
Jul-31-22 08:22AM	What You Need To Know About scPharmaceuticals Inc.'s (NASDAQ:SCPH) Investor Composition (Simply Wall St.)
Jul-13-22 08:00AM	scPharmaceuticals Inc. to Participate in the Maxim Group LLC Late-Stage Advancements in Heart Failure Therapeutics and Management Panel Discussion (GlobeNewswire)
Jul-12-22 08:00AM	scPharmaceuticals Inc. Announces Positive Results from the AT HOME-HF Phase 2 Pilot Study in Heart Failure (GlobeNewswire)

scPharmaceuticals, Inc. engages in the development of transformative pharmaceutical products for subcutaneous delivery. Its products include FUROSCIX, a furosemide injection which is used as parenteral diuretic in treating heart failure and scCeftriaxone, used as parenteral antibiotic outside the hospital setting. The company was founded by Pieter Muntendam and Bertram Pitt in February 2013 and is headquartered in Burlington, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
SCHAEFFER LEONARD D	Director	Aug 26 '24	Option Exercise	2.58	11,347	29,308	54,451	Aug 28 04:30 PM
ORBIMED ADVISORS LLC	10% Owner	Aug 13 '24	Buy	4.00	500,000	2,000,000	5,806,670	Aug 15 04:51 PM
Nokes Rachael	CFO and Treasurer	Aug 06 '24	Option Exercise	0.00	10,445	0	72,851	Aug 08 04:15 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SCPH

scPharmaceuticals Inc

Upgrade your FINVIZ experience